Targeting RARγ, by the AGN205728 and LY2955303 antagonists and acacetin, and interference with ATRA synthesis, by 637A, DIMATE, NCT-501, silybin, and solomargine, were effective against cancer stem cells. The gene discussed is RARG; the disease is cancer.